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Sir, 16 
Recently, Hall and Schwarz1 have suggested the need for a universally consistent 17 
antibiotic resistance gene nomenclature system in order to replace the current 18 
multiple and incompatible systems which exist. They arbitrarily proposed a threshold 19 
value of >2% difference of either the nucleotide or amino acid sequence, or both, as 20 
the cut-off for assigning a new gene in order to stimulate debate within the field.  21 
 22 
We welcome this suggestion and subsequent discussions, and agree that resistance 23 
gene nomenclature systems need updating and aligning in order to address the 24 
increasing availability of genetic data and our understanding of the molecular 25 
evolution of resistance genes. We would, however, like to add a note of caution that 26 
the arbitrary >2% cut-off may not be universally appropriate.  27 
 28 
In the case of the tetracycline resistance genes, covering the three known 29 
mechanistic classes of protein (ATP-dependant efflux, ribosomal protection and 30 
enzymatic inactivation), the nomenclature system is based on amino acid identity.  A 31 
new determinant must show <80% amino acid identity to known determinants to be 32 
designated a new class.2  33 
 34 
While Hall and Schwartz3 suggest a cut-off of >2% will reduce the number of gene 35 
designations for those encoding OXA ß-lactamases, the opposite will in fact be true 36 
for the tetracycline resistance genes, as indicated by Jacoby et al.4 Taking tet(M) as 37 
an example, there are well over 100 sequences within the NCBI database under this 38 
gene class. To implement a >2% cut-off for new gene designations would 39 
dramatically increase the number of tetracycline resistance genes which once 40 
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belonged to the tet(M) class. Additionally this increase in new gene designations 41 
would be compounded by the fact that there are at least 59 other tetracycline 42 
resistance gene classes currently assigned,5 many with multiple examples showing 43 
>2% sequence divergence. 44 
 45 
Furthermore, such a cut-off would also cause confusion and complications in the 46 
identification of a subclass of the ribosomal protection protein encoding genes known 47 
as the mosaic tetracycline resistance genes, which have an atypical evolutionary 48 
path involving naturally occurring recombination between two or more progenitor 49 
genes.6 These currently have their own version of a nomenclature system indicating 50 
their mosaic ancestry and this would disappear if a >2% divergence rule was 51 
implemented. 52 
 53 
We propose here to contact all investigators involved in the historical and current 54 
discovery, annotation, naming and curation of tetracycline resistance genes, and will 55 
facilitate a discussion in order to determine if there is a consensus on any proposed 56 
change to the current nomenclature system. We urge stakeholders to contact the 57 
authors of this comment in order to indicate their interest in participation. Following 58 
this process, we will report any agreement or hurdles perceived within the field. We 59 
suggest other investigators involved in the nomenclature of other resistance genes 60 
do the same and it is possible that these subgroups could form the basis of a larger 61 
committee as proposed by Evans.7 62 
 63 
 64 
 65 
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Transparency declarations 66 
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